Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vasoactive Intestinal Peptide”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Testing effectiveness (Phase 2)Ended earlyNCT03556020
What this trial is testing

Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAH

Who this might be right for
Pulmonary Arterial Hypertension
PhaseBio Pharmaceuticals Inc. 35
Not applicableStudy completedNCT00255320
What this trial is testing

Experimental Headache Induced by Vasoactive Intestinal Polypeptide

Who this might be right for
Healthy Volunteers, Headache, Migraine, Hemodynamics, VIP, SPECT, Ultrasound
Danish Headache Center 12
Not applicableNot Yet RecruitingNCT07832032
What this trial is testing

Biological Profiles of Neuropeptides, Neurotrophins and miRNA in Migraine

Who this might be right for
Migraine
Nordlandssykehuset HF 60
Not applicableStudy completedNCT01563757
What this trial is testing

Plastic Bronchitis and Protein Losing Enteropathy in Children With Single Ventricle Physiology

Who this might be right for
Fontan Physiology Patients With PB or PLEFontan Physiology Patients Without PB or PLE
Medical College of Wisconsin 20
Early research (Phase 1)Study completedNCT03315507
What this trial is testing

Assess the Safety, Tolerability, and Hemodynamic Response of PB1046 in Subjects With PAH

Who this might be right for
Pulmonary Arterial Hypertension
PhaseBio Pharmaceuticals Inc. 3
Not applicableStudy completedNCT03989817
What this trial is testing

The Effects of a Long-lasting Infusion of Vasoactive Intestinal Peptide (VIP) on Headache, Cranial Hemodynamic and Autonomic Symptoms in Healthy Volunteers

Who this might be right for
Headache Disorders
Danish Headache Center 12
Not applicableStudy completedNCT00272896
What this trial is testing

Hemodynamic and Headache-Inducing Effect of Intravenous Vasoactive Intestinal Peptide in Migraineurs

Who this might be right for
HeadacheMigraineVasoactive Intestinal Peptide+1 more
Danish Headache Center 12
Early research (Phase 1)Study completedNCT00004494
What this trial is testing

Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis

Who this might be right for
SepsisRespiratory Distress SyndromeRespiratory Distress Syndrome, Adult
Stony Brook University 18
Not applicableStudy completedNCT04260035
What this trial is testing

The Effects of a Long-lasting Infusion of Vasoactive Intestinal Peptide (VIP) in Episodic Migraine Patients

Who this might be right for
MigrainePainNeurologic Manifestations+3 more
Danish Headache Center 21
Large-scale testing (Phase 3)WithdrawnNCT05137795
What this trial is testing

Inhaled ZYESAMI (Aviptadil Acetate) for Treatment of Severe COVID-19

Who this might be right for
SARS-CoV 2COVIDARDS+3 more
APR Applied Pharma Research s.a.
Testing effectiveness (Phase 2)Ended earlyNCT04433546
What this trial is testing

Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).

Who this might be right for
Acute Respiratory Distress SyndromeCoronavirusHypoxic Respiratory Failure+15 more
PhaseBio Pharmaceuticals Inc. 54
Large-scale testing (Phase 3)Ended earlyNCT04360096
What this trial is testing

Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19

Who this might be right for
SARS-CoV 2COVIDARDS+3 more
APR Applied Pharma Research s.a. 144
Not applicableStudy completedNCT00464932
What this trial is testing

Vasoactive Intestinal Peptide in COPD

Who this might be right for
COPDPulmonary Hypertension
Medical University of Vienna 34